DNA

Willow Launches New Pumping and Feeding Accessories to Expand Support to Breastfeeding Mothers

Mom-led company introduces new products designed for effortless breast milk collection and storage after successful 2024 growth SAN FRANCISCO, Jan.…

11 months ago

Liberation Labs Closes $50.5 Million Convertible Note

Brings total deployable capital raised to date to $125 million and will enable completion of first biomanufacturing plant in Richmond,…

11 months ago

Precision AQ Launches Navigator365™ Matrix, an Advanced Platform for Identifying Digital Opinion Leaders to Activate and Amplify Brand Messages

The latest addition to the Navigator365™ Omnichannel product family transforms how life sciences companies engage with digital influencers through actionable insights…

11 months ago

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

Opening plenary session features latest fetal fraction amplification researchSALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…

11 months ago

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer…

11 months ago

PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025

PETACH TIKVA, Israel, Jan. 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming…

11 months ago

Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+…

11 months ago

Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that…

11 months ago

Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development

Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2 Planned workforce reduction…

11 months ago

Transmission Electron Microscope Market to grow by USD 528.8 Million (2024-2028), driven by nanotechnology focus, AI-driven market transformation – Technavio

NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global transmission electron microscope…

11 months ago